FDA-Vaccines and Related Biological Products Advisory Committee- Full meeting

On 6/7/2022, the U.S. Food and Drug Administration held a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) to discuss an Emergency Use Authorization request from Novavax for a COVID-19 vaccine for individuals 18 and older.

The full FDA meeting is 7 hours long. For your convince the meeting has been broken down into 3 parts with breaks omitted. The link to the full meeting is below.

*Part 1 FDA Meeting:
https://rumble.com/v187jif-part-1-fda-vaccines-and-related-biological-products-advisory-committee.html

*Part 2 FDA Meeting:
https://rumble.com/v187l0v-part-2-fda-vaccines-and-related-biological-products-advisory-committee.html

*Part 3 FDA Meeting:
https://rumble.com/v189x9y-part-3-fda-vaccines-and-related-biological-products-advisory-committee.html

Sources:
Vaccines and Related Biological Products Advisory Committee June 7, 2022 Meeting Briefing Document -
Source- FDA
https://www.fda.gov/media/158912/download

Vaccines and Related Biological Products Advisory Committee June 7, 2022 Meeting Draft Roster-
https://www.fda.gov/media/158916/download